Storia in 2 fonti

The FDA just cleared a maggot-based wound treatment from a Singapore startup

The US Food and Drug Administration has cleared Medifly Maggots, a prescription wound-care product from Singapore-based Cuprina, for use in maggot debridement therapy.

Raccontata da

gizmodo.com

techspot.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

techspot.comStai leggendo2 mesi fa

The FDA just cleared a maggot-based wound treatment from a Singapore startup

FDA clears Medifly Maggots from Cuprina for chronic non-healing wound debridement affecting 1-2% of developed-world patients. Validates biotech solution vs. antimicrobial resistance; Cuprina monopolizes FDA-authorized larvae species, establishing market leadership in precision wound care.

originale

gizmodo.com2 mesi fa

Say Hello to the New Species of Fly Officially Approved to Clean Human Wounds

The FDA has cleared Lucilia cuprina larvae for use in maggot debridement therapy.

Leggi questa versione → originale

Timeline cronologica

lunedì 22 giugno 2026·gizmodo.com
Say Hello to the New Species of Fly Officially Approved to Clean Human Wounds
The FDA has cleared Lucilia cuprina larvae for use in maggot debridement therapy.
lunedì 22 giugno 2026·techspot.com
The FDA just cleared a maggot-based wound treatment from a Singapore startup
The US Food and Drug Administration has cleared Medifly Maggots, a prescription wound-care product from Singapore-based Cuprina, for use in maggot debridement therapy.